CorMedix Inc.

3.59 USD
+0.03 (+0.84%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

CorMedix Inc. stock is up 11.49% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42.86% of the previous 13 December’s closed higher than November. In the last 2 Unusual Options Trades, there were 2 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
11 Oct 17:24 17 Nov, 2023 3.00 PUT 500 202
15 Nov 20:54 15 Dec, 2023 4.00 PUT 490 964

About CorMedix Inc.

CorMedix Inc. focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings.

  • Needham
    Wed Nov 15, 13:49
  • RBC Capital
    Wed Nov 15, 13:46
  • Truist Securities
    Wed Nov 15, 13:45
  • JP Morgan
    Wed Nov 15, 12:55